Abstract
Background: Chronic alcohol abuse is a risk factor for osteoporosis and fractures, whose pathogenesis is still unclear. We investigated the influence of alcoholism and other risk factors on calcium and skeletal metabolism, bone mineral density (BMD), and fractures. Materials and methods: In 51 chronic male alcoholics without liver failure and 31 healthy controls, serum total and ionised calcium, phosphate, creatinine, 25-hydroxy vitamin D (25OHD), PTH, total (ALP) and bone-specific (BALP) alkaline phosphatase, osteocalcin (BGP), carboxy-terminal telopeptide of type I collagen (β-CTx), osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) were assessed. In patients only, we also measured serum testosterone, 17-β estradiol, LH, and IGF-I. BMD was measured by dual energy x-ray absorptiometry at lumbar spine (LS-) and femur [neck (FN-) and total hip (TF-)]. Vertebral fractures were identified by a semiquantitative method on thoraco-lumbar spine x-ray, non-vertebral fractures (as life-style factors) by history. Results: Alcoholics were leaner, had significantly higher ALP and BALP, and lower BGP and 25OHD levels than controls. No significant difference in other calcium and bone metabolism parameters was found. OPG/RANKL ratio was significantly higher in alcoholics. Beta-CTx negatively correlated with abuse duration. OPG positively correlated with daily alcohol assumption and with indexes of liver cytolysis. Though LS-, FN-and TF-BMD of alcoholics and controls did not significantly differ, patients had a much higher prevalence of vertebral fractures. The same was found considering both vertebral and non-vertebral fractures. Conclusions: Ethanol-induced skeletal damage seems mainly dependent on negative effects on bone formation. Lifestyle factors and traumas likely contribute to the high fracture incidence of alcohol abusers, independently of BMD.
Similar content being viewed by others
References
Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005, 16: 737–42.
Santolaria F, Gonzàlez-Reimers E, Pérez-Manzano JL, et al. Osteopenia assessed by body composition analysis is related to malnutrition in alcoholic patients. Alcohol 2000, 22: 147–57.
Baron JA, Farahmand BY, Weiderpass E, et al. Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 2001, 161: 983–8.
Bode C, Bode JC. Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol 2003, 17: 575–92.
Bannister P, Losowsky MS. Ethanol and hypogonadism. Alcohol Alcohol 1987, 22: 213–7.
Groote Veldman R, Meinders AE. On the mechanism of alcohol-induced pseudo-Cushing’s syndrome. Endocr Rev 1996, 17: 262–8.
Lavigne JA, Baer DJ, Wimbrow HH, et al. Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women. Am J Clin Nutr 2005, 81: 503–7.
Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Transient hypoparathyroidism during acute alcohol intoxication. N Engl J Med 1991, 324: 721–7.
Friday KE, Howard GA. Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism 1991, 40: 562–5.
Sampson HW. Effect of alcohol consumption on adult and aged bone: a histomorphometric study of the rat animal model. Alcohol Clin Exp Res 1998, 22: 2029–34.
Maran A, Zhang M, Spelsberg TC, Turner RT. The dose-response effects of ethanol on the human fetal osteoblastic cell line. J Bone Miner Res 2001, 16: 270–6.
Dai J, Lin D, Zhang J, et al. Chronic alcohol ingestion induces osteodastogenesis and bone loss through IL-6 mice. J Clin Invest 2000, 106: 887–95.
Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315: 841–6.
Barger-Lux MJ, Heaney RP. Caffeine and calcium economy revisited. Osteoporosis Int 1995, 5: 97–102.
Lloyd T, Johnson-Rollings N, Eggli DF, Kieselhorst K, Mauger EA, Cusatis DC. Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. J Am Coll Nutr 2000, 19: 256–61.
Fabbri A, Marchesini G, Morselli-Labate AM, et al. Positive blood alcohol concentration and road accidents. A prospective study in an Italian emergency department. Emerg Med J 2002, 19: 210–4.
Education Materials. National Institute on Alcohol Abuse and Alcoholism of the National Institute of Health, www.ni-aaa.nih.gov/guide
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843: 1–129.
Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 9: 1137–48.
Advisory Panel on Testosterone Replacement in Men. Report of the National Institute on Aging Advisory Panel on testosterone replacement in men. J Clin Endocrinol Metab 2001, 86: 4611–4.
Peris P, Guanabens N, Parés A, et al. Vertebral fractures and osteopenia in chronic alcoholic patients. Calcif Tissue Int 1995, 57: 111–4.
Santolaria F, Perez-Cejas A, Alemán MR, et al. Low serum leptin levels and malnutrition in chronic alcohol misusers hospitalized by somatic complications. Alcohol Alcohol 2003, 38: 60–6.
Jensen GF. Osteoporosis of slender smoker revisited by epidemiological approach. Eur J Clin Invest 1986, 16: 239–42.
Høidrup S, Prescott E, Sørensen Tl, et al. Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol 2000, 29: 253–9.
Pedrazzoni M, Vescovi PP, Maninetti L, et al. Effect of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993, 129: 42–5.
Idris AI, van’t Hof RJ, Greig IR, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoids receptors. Nature Med 2005, 11: 774–9.
Ofek O, Karsak M, Leclerc N, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 2006, 103: 696–701.
Kasukawa Y, Miyakoshi N, Mohan S. The anabolic effects of GH/IGF system on bone. Curr Pharm Des 2004, 10: 2577–92.
Gong Z, Wezeman FH. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res 2004, 28: 468–79.
Garcia-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, et al. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 2006, 41: 261–6.
Monegal A, Navasa M, Peris P, et al. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. Liver Int 2007, 27: 492–7.
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005, 115: 3318–25.
Khosla S, Arrighi HM, Melton LJ 3rd, et al. Correlates of osteoprotegerin levels in women and men. Osteoporos Int 2002, 13: 394–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santori, C., Ceccanti, M., Diacinti, D. et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest 31, 321–326 (2008). https://doi.org/10.1007/BF03346365
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346365